Suppr超能文献

口服抗凝治疗及其控制:一项国际调查。

Oral anticoagulant therapy and its control: an international survey.

作者信息

Lam-Po-Tang P R, Poller L

出版信息

Thromb Diath Haemorrh. 1975 Nov 15;34(2):419-25.

PMID:1198405
Abstract

A survey for the International Study Group for Anticoagulant Control has been conducted in which a questionnaire was sent to members in 39 countries. Information based on 37 replies obtained indicated that the most widely used test in oral anticoagulant therapy is the Quick one stage prothrombin estimation. There is a great diversity in the method of reporting prothrombin time results. Percentage activity of normal on the basis of saline dilution curves is the most popular. Only six countries have national or regional systems for anticoagulant control. Recommendations for the therapeutic range of dosage vary widely. The upper limit in one country may be the lower limit in another. In many centres doses of anticoagulant drugs are advocated which elsewhere are considered either inadequate anticoagulation or dangerous overdosages. The variation of therapeutic range may still be considerable even when a standard thromboplastin is available. Data collected from the survey indicates the need for urgent measures to provide a uniform of laboratory control of clinical dosage of anticoagulant drugs. Until such measures are implemented it is meaningless to try to compare the efficacy of oral anticoagulant therapy from country to country or even to attempt multicentre trials within national boundaries.

摘要

国际抗凝控制研究组开展了一项调查,向39个国家的成员发送了调查问卷。基于收到的37份回复得出的信息表明,口服抗凝治疗中使用最广泛的检测方法是一期Quick凝血酶原测定。凝血酶原时间结果的报告方法存在很大差异。基于盐水稀释曲线的正常活性百分比是最常用的。只有六个国家有国家或地区抗凝控制体系。关于治疗剂量范围的建议差异很大。一个国家的上限在另一个国家可能是下限。在许多中心所提倡的抗凝药物剂量,在其他地方要么被认为抗凝不足,要么被认为是危险的过量用药。即使有标准的凝血活酶,治疗范围的差异可能仍然相当大。从调查中收集的数据表明,迫切需要采取措施,以统一对抗凝药物临床剂量进行实验室控制。在实施这些措施之前,试图比较不同国家口服抗凝治疗的疗效,甚至在国界内进行多中心试验都是没有意义的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验